Unfermented chickpea
OtherFrozen meals containing 100 g unfermented chickpeas
NCT Number: NCT06134076
The goal of this clinical trial is to learn about the effects of consuming fermented pulses (certain types of legumes like chickpeas or lentils) in healthy people. The main questions it aims to answer are:
1. How does consuming the fermented foods impact the gut microbiome? 2. Does this interaction between the fermented foods and the gut microbiome affect inflammation?
Participants will be asked to consume two sets of prepared meals, one containing unfermented pulses, the other containing fermented pulses.
Researchers will compare the gut microbiome and inflammation between these two diets.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Interventional
Not applicable
The rationale for the research is that fermentation of pulses can reduce the concentration of compounds that suppress butyrate producing bacteria and butyrate production. This will in turn boost butyrate production during consumption of these fermented pulses relative to that in unfermented pulses. This in turn will lead to lower inflammation in people consuming fermented pulses. To best study this question the investigators will utilize a cross-over design trial where participants will consume daily meals containing either fermented or unfermented pulses (chickpeas), followed by a washout period and then a period of consuming the other type of pulse. The investigators hypothesize that those consuming the fermented pulses will experience a significant decrease in inflammatory markers driven by increased butyrate production by gut bacteria.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Frozen meals containing 100 g unfermented chickpeas
Frozen meals containing 100 g fermented chickpeas
Time frame: At 2 weeks (baseline), 4 weeks (after first intervention), 8 weeks (after second intervention)
Measured in blood (IL-1β, IL-6, IL-10, IL-12, IFN-γ, TNF-α) and in feces (NGAL, calprotectin)
Time frame: At 2 weeks (baseline), 4 weeks (after first intervention), 8 weeks (after second intervention)
Measurement of acetate, propionate and butyrate in feces
Time frame: At 2 weeks (baseline), 4 weeks (after first intervention), 8 weeks (after second intervention)
Measured by fecal 16S rRNA gene sequencing
Contact information is provided by the study sponsor or research team.
Andy Paff, MS
CONTACT
Darrell W Cockburn, PhD
CONTACT
Penn State University
Other
Impact of Fermented Pulses on Inflammation and the Gut Microbiota
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07602166
Cardiovascular Diseases, High Blood Pressure
Nashville, Tennessee, United States
View Trial DetailsNCT07534332
Arthritis, Arthritis, Rheumatoid
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT07699367
Atrophy, Inflammation
Salt Lake City, Utah, United States
View Trial DetailsNCT07679763
Cardiovascular Diseases, Cardiovascular Diseases (CVD)
Ankara, Turkey (Türkiye)
View Trial Details